As one of the five core partners that make up USAID’s EQUIP Consortium, Anova is working to address the healthcare needs of Key Populations in relation to 90-90-90 targets and in relation to pre-exposure prophylaxis (PrEP). EQUIP is an effective and efficient response mechanism to achieving global HIV epidemic control by delivering the right intervention at the right place.
Recently, EQUIP launched Namibia’s first ever PrEP (Pre-exposure prophylaxis) driven campaign with great results.
In this podcast, Senior Implementing Officer for the Anova Global Programme, Dianne Massawe, shares some of her experiences of the programme. She discusses why it was so effective, what some of the challenges were, and what she hopes to see manifest in the foreseeable future for EQUIP if she could use a magic wand.
[soundcloud id='404016729' height='false']
The Anova Health Institute does not believe that the distribution of Pre-Exposure Prophylaxis (PrEP) will have any significant effect on the level of promiscuous sexual behavior.
When the contraceptive pill was first introduced, many feared that this would result in more promiscuity, but studies have shown that this was not the case. Instead, the “pill” has drastically diminished the number of unwanted pregnancies.
Similarly, when condoms first became available, there was an outcry that promiscuity would be made more prevalent. Research has dispelled this too, and rather, the spread of STIs has become much less prevalent.
With regards to promiscuous behavior, the use of PrEP should prove to have as little an effect as the condom and the oral contraceptive, but it will diminish the rate of HIV transmission, which is the objective.
Participants have not recorded a significant increase in sexual partners in any of the PrEP programmes conducted globally to date.